Open Government Portal
Found 10 records similar to How to quarantine (self-isolate) at home when you may have been exposed to COVID-19 and have no symptoms
COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications.
Variant strains of SARS-CoV-2 are emerging that may affect the level of protection provided by currently authorized COVID-19 vaccines. As a result, manufacturers are adapting authorized COVID-19 vaccines to provide protection against infection and disease caused by virus variants.
COVID-19 is a new disease. A vaccine or therapy to treat or prevent this disease has not yet been developed. However, the COVID-19 pandemic has resulted in a global review of therapies that may be used to treat or prevent the disease. Canada is speeding up the importation and sale of medical devices used to diagnose, treat or prevent COVID-19.
"The Cyber Centre has seen an increase in reports of malicious actors using the CoronaVirus (COVID-19) in phishing campaigns and malware scams.
The response to COVID-19 is being led by Public Health Agency of Canada (PHAC), with support from public health officials and agencies across Canada. For information about COVID-19 please visit the Government of Canada’s COVID-19 Outbreak Update page for the most up to date information."
What being vaccinated against COVID-19 means for me. By getting vaccinated, you benefit from the protection you get against COVID-19 and the easing of restrictive measures in your community.
COVID-19 vaccine ingredients in the Pfizer-BioNTech, Moderna and AstraZeneca vaccines.
Several different types of treatments for COVID-19 have been developed. Examples include drugs that reduce or stop the virus from multiplying in human cells and drugs that treat the symptoms of COVID-19.
The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines builds on the Consortium's May 2020 pledge to work together to counter the COVID-19 global pandemic.
COVID-19 is an illness caused by a coronavirus. Human coronaviruses are common and are typically associated with mild illnesses, similar to the common cold.
This document provides guidance to health authorities working to protect people in Canada from extreme heat by considering COVID-19 in heat alert and response planning. COVID-19 information evolves rapidly and this document is based on the medical community's current understanding of this issue.